|
2025
|
Invention
|
Antigen binding polypeptides, polypeptide complexes and methods of use thereof.
Disclosed are an... |
|
|
Invention
|
Nk cells with an increased antibody-dependent cellular toxicity (adcc) against tumors.
Disclosed... |
|
2024
|
Invention
|
Multi-cyclic irak and flt3 inhibiting compounds and uses thereof. Some embodiments of the disclos... |
|
|
Invention
|
Inhibitors of the surface expression of the voltage-gated sodium ion channel 1.7 (nav1.7) and the... |
|
|
Invention
|
Codon-optimized reduced-size atp7a cdna and uses for treatment of copper transport disorders.
Di... |
|
|
Invention
|
Compositions and methods for producing dendritic cell-based vaccines with enhanced efficacy. Comp... |
|
|
Invention
|
Herv-e antibodies and methods of their use. Monoclonal antibodies and antigen binding fragments t... |
|
|
Invention
|
Multi-cyclic irak1 and irak4 inhibiting compounds and uses thereof. The present disclosure provid... |
|
|
Invention
|
Polypeptides, nucleic acid molecules, compositions, and related methods.
Some embodiments of the... |
|
|
Invention
|
Nk cells or t cells expressing hematopoietic growth factor receptors and methods of use.
Modifie... |
|
2023
|
Invention
|
Anti-b-cell maturation antigen chimeric antigen receptors with human domains.
Provided are chime... |
|
|
Invention
|
Nk cells or t cells expressing chimeric hematopoietic growth factor receptors and methods of use.... |
|
|
Invention
|
Novel crispr enzymes and systems.
The invention provides for systems, methods, and compositions ... |
|
|
Invention
|
Anti-sars-cov-2 antigen binding polypeptides, polypeptide complexes and methods of use thereof.
... |
|
|
Invention
|
Treatment of fibrotic disorders with metabotropic glutamate receptor 5 antagonists or/and cannabi... |
|
|
Invention
|
Compositions and methods for detecting lymphatic filariasis.
Compositions for detecting agents c... |
|
|
Invention
|
Systems and methods to identify and treat subjects at risk for obstetrical complications. Provide... |
|
|
Invention
|
Modified factor xa polypeptides and methods of use.
Modified Factor Xa polypeptides having funct... |
|
|
Invention
|
Short apolipoprotein e mimetic peptides and methods of use.
ApoE mimetic peptides of 8-17 amino ... |
|
|
Invention
|
Recombinant polypeptides comprising single-domain antibodies targeting herv-k subtype hml-2.
The... |
|
|
Invention
|
Micrornas and methods of their use.
Disclosed herein are methods of treating a tumor in a subjec... |
|
|
Invention
|
Compounds for improving mrna splicing.
Provided herein are compounds useful for improving mRNA s... |
|
|
Invention
|
Methods and devices for collecting and analyzing aerosol particles. A device (200) for collecting... |
|
2022
|
Invention
|
N-((adamantan-1-yl)carbamoyl)-benzenesulfonamide derivatives as soluble epoxide hydrolase inhibit... |
|
|
Invention
|
Crystal structure of crispr cpf1.
The invention provides for systems, methods, and compositions ... |
|
|
Invention
|
Augmentation of innate and adaptive immunity by inhibition of interaction of lilrbs with mhc-1. M... |
|
|
Invention
|
Methods and compositions for inhibiting polyomavirus-associated pathology.
Disclosed herein are ... |
|
|
Invention
|
D3 dopamine receptor-selective negative allosteric modulators.
Compounds of Formula I, Formula I... |
|
|
Invention
|
Vaccine candidates for human respiratory syncytial virus (rsv) having attenuated phenotypes. Repo... |
|
|
Invention
|
Method for inhibiting zika virus infection. The present invention concerns the use of compounds a... |
|
|
Invention
|
Short apoc-ii mimetic peptides and methods of use.
ApoC-II mimetic peptides of 19-35 amino acids... |
|
|
Invention
|
Lipoprotein targeting protease inhibitors and uses.
Described herein is the design and construct... |
|
|
Invention
|
Il-13ralpha2 targeted immunotoxins and methods of use.
The disclosure relates to immunotoxins, p... |
|
|
Invention
|
Human insulin c-alpha-peptides and methods of use.
Methods of treating a subject with diabetes o... |
|
|
Invention
|
Il-13ra2 chimeric antigen receptors and methods of use.
Immunotherapies, particularly chimeric a... |
|
|
Invention
|
Adjuvanted mucosal subunit vaccines for preventing sars-cov-2 transmission and infection.
Immuno... |
|
2021
|
Invention
|
Multi-cyclic irak and flt3 inhibiting compounds and uses thereof.
Some embodiments of the disclo... |
|
|
Invention
|
Single-cell profiling of chromatin occupancy and rna sequencing.
Compositions and methods for de... |
|
|
Invention
|
Modified nk cells with reduced ccr5 expression and methods of their use.
Modified NK cells with ... |
|
|
Invention
|
Synthetic lethality-mediated precision oncology via tumor transcriptome.
The present disclosure ... |
|
|
Invention
|
Methotrexate analogs and methods of use.
Compounds having general formula I
Compounds having g... |
|
|
Invention
|
Alk2 inhibitors and methods for inhibiting bmp signaling. The present invention provides small-mo... |
|
|
Invention
|
Margaric acid decreases piez02-mediated pain.
Described herein is a method of treating pain by a... |
|
|
Invention
|
Methods and systems for predicting rates of progression of age-related macular degeneration.
Dis... |
|
|
Invention
|
Use of statins to treat or prevent drug-induced hearing loss.
The invention relates to methods a... |
|
2020
|
Invention
|
Cd206 modulators their use and methods for preparation.
Compounds of Formula I, Formula II, and ... |
|
|
Invention
|
T-cell compositions and methods of making and using the same.
The present disclosure provides ad... |
|
|
Invention
|
Cd28h domain-containing chimeric antigen receptors and methods of use.
Chimeric antigen receptor... |
